In Vitro Assessment for Antimicrobial Activity Against SARS-CoV-2
$744,070N02FY2020AINIH
University Of Pennsylvania, Philadelphia PA
Investigators
Abstract
This contract provides in vitro testing of potential anti-viral agents for novel SARS-CoV-2. COVID-19
View original record on NIH RePORTER →